Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-21 | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph
(Chief Technical Officer) |
S | Common Stock | D | 18235 | $40.34 - $40.34 | $735,599 |
| 2024-03-20 | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden
(EVP, Head of North America) |
S | Common Stock | D | 18235 | $38.22 - $39.33 | $707,004 |
| 2024-03-19 | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C
(Chief Financial Officer) |
S | Common Stock | D | 15515 | $39.22 - $39.22 | $608,498 |
| 2024-03-19 | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph
(Chief Technical Officer) |
S | Common Stock | D | 15515 | $39.22 - $39.22 | $608,498 |
| 2024-03-19 | RHYTHM PHARMACEUTICALS, INC. | Meeker David P
(President and CEO) |
S | Common Stock | D | 45494 | $39.22 - $39.22 | $1,784,274 |
| 2024-03-19 | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann
(EVP, Head of International) |
S | Common Stock | D | 16000 | $39.22 - $39.22 | $627,520 |
| 2024-03-19 | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden
(EVP, Head of North America) |
S | Common Stock | D | 15515 | $39.22 - $39.22 | $608,498 |
| 2024-03-19 | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J.
(Chief Human Resources Officer) |
S | Common Stock | D | 15515 | $39.22 - $39.22 | $608,498 |
| 2024-02-16 | RHYTHM PHARMACEUTICALS, INC. | Meeker David P
(President and CEO) |
A | Common Stock | A | 99000 | $0.00 - $0.00 | $0 |
| 2024-02-16 | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann
(EVP, Head of International) |
A | Common Stock | A | 33750 | $0.00 - $0.00 | $0 |
| 2024-02-16 | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J.
(Chief Human Resources Officer) |
A | Common Stock | A | 33750 | $0.00 - $0.00 | $0 |
| 2024-02-16 | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C
(Chief Financial Officer) |
A | Common Stock | A | 33750 | $0.00 - $0.00 | $0 |
| 2024-02-16 | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph
(Chief Technical Officer) |
A | Common Stock | A | 33750 | $0.00 - $0.00 | $0 |
| 2024-02-16 | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden
(EVP, Head of North America) |
A | Common Stock | A | 33750 | $0.00 - $0.00 | $0 |
| 2024-02-13 | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph
(Chief Technical Officer) |
S | Common Stock | D | 2954 | $50.00 - $50.01 | $147,710 |
| 2024-02-12 | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C
(Chief Financial Officer) |
S | Common Stock | D | 1918 | $49.82 - $51.38 | $97,440 |
| 2024-02-12 | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann
(EVP, Head of International) |
S | Common Stock | D | 2551 | $49.84 - $51.38 | $129,595 |
| 2024-02-12 | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden
(EVP, Head of North America) |
S | Common Stock | D | 1638 | $49.83 - $51.38 | $83,206 |
| 2024-02-09 | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph
(Chief Technical Officer) |
S | Common Stock | D | 73038 | $48.24 - $51.52 | $3,680,196 |
| 2024-02-09 | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph
(Chief Technical Officer) |
M | Common Stock | A | 69190 | $21.38 - $21.38 | $1,479,282 |
| 2024-02-12 | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J.
(Chief Human Resources Officer) |
S | Common Stock | D | 696 | $51.38 - $51.38 | $35,760 |
| 2024-02-01 | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden
(EVP, Head of North America) |
S | Common Stock | D | 1492 | $45.06 - $45.06 | $67,229 |
| 2024-02-01 | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C
(Chief Financial Officer) |
S | Common Stock | D | 1616 | $45.06 - $45.06 | $72,816 |
| 2024-02-01 | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph
(Chief Technical Officer) |
S | Common Stock | D | 1324 | $45.06 - $45.06 | $59,659 |
| 2024-02-01 | RHYTHM PHARMACEUTICALS, INC. | Meeker David P
(President and CEO) |
S | Common Stock | D | 4361 | $45.06 - $45.06 | $196,506 |
| 2024-02-01 | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J.
(Chief Human Resources Officer) |
S | Common Stock | D | 946 | $45.06 - $45.06 | $42,626 |
| 2023-12-29 | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C
(Chief Financial Officer) |
M | Common Stock | A | 10500 | $6.88 - $6.88 | $72,240 |
| 2023-11-14 | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph
(Chief Technical Officer) |
S | Common Stock | D | 27890 | $32.07 - $32.07 | $894,329 |
| 2023-11-14 | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph
(Chief Technical Officer) |
M | Common Stock | A | 27890 | $6.80 - $6.80 | $189,652 |
| 2023-11-08 | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden
(EVP, Head of North America) |
S | Common Stock | D | 9150 | $27.37 - $29.31 | $260,286 |
| 2023-11-08 | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden
(EVP, Head of North America) |
M | Common Stock | A | 9150 | $6.80 - $6.80 | $62,219 |
| 2023-11-03 | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden
(EVP, Head of North America) |
S | Common Stock | D | 80 | $28.00 - $28.00 | $2,240 |
| 2023-11-03 | RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden
(EVP, Head of North America) |
M | Common Stock | A | 80 | $6.80 - $6.80 | $544 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |